Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8168645 Arylsulfonamide compounds

Patent 8168645 was granted and assigned to Genentech on May, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Brad Edmund Sleebs0

Jonathan Bayldon Baell0

Michael F. T. Koehler0

Wayne J. Fairbrother0

Guillaume Laurent Lessene0

John A. Flygare0

Date of Patent

May 1, 2012

0

Patent Application Number

125138350

Date Filed

November 15, 2007

0

Patent Citations Received

US Patent 11963957 Treating cardiovascular disease by selectively eliminating senescent cells

0

US Patent 11980616 Treating liver disease by selectively eliminating senescent cells

0

Patent Primary Examiner

Rebecca Anderson

0

Patent abstract

The invention relates generally to small molecules that mimic the biological activity of certain peptides and proteins, to compositions containing them and to their use. In particular, the invention relates to compounds of the general formula (I) that mimic the biological activity of BH3-only proteins and are capable of binding to and neutralizing pro-survival Bcl-2 proteins:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8168645 Arylsulfonamide compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.